Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease

Neuroscience Letters

Volumn 423, Issue 3, 2007, Pages 194-199

  Perez Buira, S ^a   Barrachina, M ^a   Rodriguez, A ^a   Albasanz, J L ^b   Martin M ^b   Ferrer, I ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Adenosine receptors; Adenylyl cyclase; Argyrophilic grain disease

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENYLATE CYCLASE; CYCLOHEXYLADENOSINE; FORSKOLIN;

ADULT; AGED; ARGYROPHILIC GRAIN DISEASE; ARTICLE; BRAIN DISEASE; CADAVER; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NEUROCHEMISTRY; NEUROMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR SENSITIVITY; SENSITIZATION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADENYLATE CYCLASE; AGED; AGED, 80 AND OVER; CADAVER; COGNITION DISORDERS; DEMENTIA; FEMALE; FORSKOLIN; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PHENYLALANINE; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RECEPTORS, PURINERGIC P1; SILVER STAINING; TAUOPATHIES;

EID: 34548132073     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.06.049     Document Type: Article

References (25)

1. Albasanz J.L., Rodriguez A., Ferrer I., and Martin M. Adenosine A2A receptors are up-regulated in Pick's disease frontal cortex. Brain Pathol. 16 (2006) 249-255
2. Angulo E., Casado V., Mallol J., Canela E., Vinals F., Ferrer I., Lluis C., and Franco R. A1 Adenosine receptors accumulate in neurodegenerative structures in Alzheimer's disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 13 (2003) 440-451
3. Arrigoni E., Rainnie D.G., McCarley R.W., and Greene R.W. Adenosine-mediated presynaptic modulation of glutamatergic transmission in the laterodorsal tegmentum. J. Neurosci. 21 (2001) 1076-1085
4. Blum D., Gall D., Galas M.C., d'Alcantara P., Bantubungi K., and Schiffmann S.N. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity. J. Neurosci. 22 (2002) 9122-9133
5. Braak H., and Braak E. Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J. Neural Transm. 105 (1998) 801-819
6. D'Alimonte I., Ballerini P., Nargi E., Buccella S., Giuliani P., Di Lorio P., Caciagli F., and Cicarelli R. Staurosporine-induced apoptosis in astrocytes is prevented by A(1) adenosine receptor activation. Neurosci. Lett. 418 (2007) 66-71
7. Dalpiaz A., and Manfredini S. Adenosine A(1) receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system. Curr. Med. Chem. 9 (2002) 1923-1937
8. Deckert J., Abel F., Kunig G., Hartmann J., Senitz D., Maier H., Ransmayr G., and Riederer P. Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificity. Neurosci. Lett. 244 (1998) 1-4
9. Dixon A.K., Gubitz A.K., Sirinathsinghji D.J., Richardson P.J., and Freeman T.C. Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol. 118 (1996) 461-468
10. Dunwiddie T.V., and Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neuroscience 24 (2001) 31-55
11. Ferrer I., Barrachina M., Tolnay M., Rey M.J., Vidal N., Carmona M., Blanco R., and Puig B. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease. Brain Pathol. 13 (2003) 62-78
12. Fredholm B.B., and Dunwiddie T.V. How does adenosine inhibit transmitter release?. Trends Pharmacol. Sci. 9 (1988) 130-134
13. Fredholm B.B., Izerman A.P., Jacobson K.A., Klotz K.N., and Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53 (2001) 527-552
14. Jellinger K.A. Dementia with grains (argyrophilic grain disease). Brain Pathol. 8 (1998) 377-386
15. Mader T.J., Menegazzi J.J., Betz A.E., Logue E.S., Callaway C.W., and Sherman L.D. Adenosine A1 receptor antagonism hastens the decay in ventricular fibrillation waveform morphology during porcine cardiac arrest. Resuscitation 71 (2006) 254-259
16. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
17. Ribeiro J.A. What can adenosine neuromodulation do for neuroprotection?. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 325-329
18. Rodríguez A., Martín M., Albasanz J.L., Barrachina M., Espinosa J.C., Torres J.M., and Ferrer I. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine PrP mice. J. Neuropathol. Exp. Neurol. 65 (2006) 964-975
19. Saito Y., Ruberu N.N., Sawabe M., Arai T., Tanaka N., Kakuta Y., Yamanouchi H., and Murayama S. Staging of argyrophilic grains: an age-associated tauopathy. J. Neuropathol. Exp. Neurol. 63 (2004) 911-918
20. Schnecko A., Witte K., Bohl J., Ohm T., and Lemmer B. Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differentially affected. Brain Res. 644 (1994) 291-296
21. Togo T., Sahara N., Yen S.H., Cookson N., Ishizawa T., Hutton M., de Silva R., Lees A., and Dickson D.W. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J. Neuropathol. Exp. Neurol. 61 (2002) 547-556
22. Tolnay M., Sergeant N., Ghestem A., Chalbot S., De Vos R.A., Jansen Steur E.N., Probst A., and Delacourte A. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathol. 104 (2002) 425-434
23. Wittendorp M.C., Von Frijtag Drabbe Künzel J., Ijzerman A.P., Boddeke H.W., and Biber K. The mouse brain adenosine A1 receptor: functional expression and pharmacology. Eur. J. Pharmacol. 487 (2004) 73-79
24. Yamamoto M., Gotz M.E., Ozawa H., Luckhaus C., Saito T., Rosler M., and Riederer P. Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease. Biochim. Biophys. Acta 1535 (2000) 60-68
25. Zhukareva V., Shah K., Uryu K., Braak H., Del Tredici K., Sundarraj S., Clark C., Trojanowski J.Q., and Lee V.M. Biochemical analysis of T proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease. Am. J. Pathol. 161 (2002) 1135-1141